Global supply snarls have thrust India into a pivotal role for Bangladesh, underscoring the power of proximity in trade. A detailed analysis reveals how pandemic-era chaos from 2020-2022 exposed Bangladesh’s overreliance on distant suppliers.
Surging container costs and port congestions led to acute shortages of drug raw materials and factory inputs. Perishable foods rotted in far-off harbors, inflating prices and sparking urgency.
India, sharing a border, proved the swiftest savior. Pre-COVID, Bangladesh imported massive API volumes from China and India for its thriving pharma sector. China’s lockdowns shifted the balance dramatically toward India.
Despite its own challenges, India ramped up land-based deliveries through key border points. Dhaka received essential cargoes in 48 hours via truck, dwarfing ocean voyages that dragged on for weeks.
South Asia’s pharma leader, Bangladesh excels in finished medicines but imports core chemicals. India filled the void reliably when China stumbled.
Energy security adds another layer: India’s pipelines and refineries enable rapid diesel shipments. While emergency aid has flowed informally, formalization lags.
Experts call for a robust, enforceable bilateral pact on crisis supplies. Such a mechanism would fortify resilience, preventing repeats of past disruptions and cementing Indo-Bangla economic ties.